Harrow, Inc. (HROW)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGMUnited StatesUS4158581094
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Harrow, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:02. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 01 Mar 2027 16:00 | 1.01 | — | — | Upcoming |
| 09 Nov 2026 16:00 | 0.30 | 0.13 | -56.9% | Miss |
| 10 Aug 2026 16:00 | -0.24 | -0.46 | -91.7% | Miss |
| 11 May 2026 16:00 | -0.33 | -0.74 | -124.2% | Miss |
| 02 Mar 2026 16:00 | 0.48 | 0.27 | -43.7% | Miss |
| 10 Nov 2025 17:00 | 0.29 | 0.33 | +13.8% | Beat |
| 11 Aug 2025 16:00 | 0.04 | 0.24 | +585.7% | Beat |
| 08 May 2025 16:00 | 0.01 | -0.38 | -5,797.2% | Miss |
| 27 Mar 2025 16:00 | 0.13 | 0.40 | +207.7% | Beat |
| 13 Nov 2024 16:00 | 0.07 | -0.05 | -171.4% | Miss |
| 07 Aug 2024 16:00 | -0.11 | -0.06 | +45.5% | Beat |
| 13 May 2024 16:00 | -0.25 | -0.28 | -12.0% | Miss |
| 19 Mar 2024 17:00 | -0.05 | -0.20 | -300.0% | Miss |
| 13 Nov 2023 16:00 | 0.03 | -0.09 | -400.0% | Miss |
| 09 Aug 2023 16:00 | — | -0.02 | — | — |
| 11 May 2023 16:00 | -0.06 | -0.03 | +50.0% | Beat |
| 23 Mar 2023 16:00 | -0.04 | 0.07 | +263.5% | Beat |
| 14 Nov 2022 16:00 | -0.03 | -0.20 | -562.0% | Miss |
| 09 Aug 2022 16:00 | 0.01 | 0.01 | 0.0% | In line |
| 05 May 2022 16:00 | -0.04 | 0.03 | +166.7% | Beat |
| 10 Mar 2022 16:00 | — | 0.01 | — | — |
| 09 Nov 2021 16:00 | -0.03 | 0.04 | +236.2% | Beat |
| 10 Aug 2021 16:00 | 0.04 | 0.09 | +118.1% | Beat |
| 11 May 2021 16:00 | 0.02 | 0.09 | +483.3% | Beat |
| 08 Mar 2021 16:00 | 0.01 | 0.07 | +1,369.8% | Beat |
| 09 Nov 2020 17:00 | -0.09 | 0.04 | +143.5% | Beat |
| 10 Aug 2020 16:00 | -0.17 | -0.14 | +16.6% | Beat |
| 11 May 2020 16:00 | -0.02 | -0.04 | -125.0% | Miss |
| 13 Mar 2020 08:00 | 0.01 | 0.02 | +274.2% | Beat |
| 13 Nov 2019 16:00 | -0.04 | — | +98.6% | — |
| 14 Aug 2019 16:00 | -0.06 | -0.05 | +18.9% | Beat |
| 09 May 2019 16:00 | -0.12 | -0.04 | +67.2% | Beat |
| 12 Mar 2019 16:00 | -0.06 | -0.06 | +6.3% | Beat |
| 13 Nov 2018 16:00 | -0.09 | -0.12 | -33.3% | Miss |
| 10 May 2017 16:00 | -0.19 | -0.21 | -10.9% | Miss |
| 21 Mar 2017 16:00 | -0.28 | -0.25 | +11.1% | Beat |
| 14 Nov 2016 16:00 | -0.34 | -0.29 | +14.7% | Beat |
| 15 Aug 2016 16:00 | -0.36 | -0.35 | +2.8% | Beat |
| 12 May 2016 16:00 | -0.27 | -0.32 | -18.2% | Miss |
| 23 Mar 2016 16:00 | -0.26 | -0.37 | -42.1% | Miss |
| 12 Nov 2015 16:00 | -0.23 | -0.31 | -34.8% | Miss |
| 12 Aug 2015 16:00 | -0.23 | -0.39 | -69.6% | Miss |
| 13 May 2015 16:00 | -0.25 | -0.33 | -32.0% | Miss |
| 12 Mar 2015 16:00 | -0.28 | -0.30 | -7.1% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 272.3M | +36.4% | -5.1M | -1.9% | -0.14 | +71.4% | 42.8M |
| 2024 | 199.6M | +53.3% | -17.5M | -8.8% | -0.49 | +34.7% | -60.9M |
| 2023 | 130.2M | +47.0% | -24.4M | -18.7% | -0.75 | -47.1% | -148.7M |
| 2022 | 88.6M | — | -14.1M | -15.9% | -0.51 | — | -6.1M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 28.38 | 33.68 | 25.76 | 30.17 | +6.83% | 8,519,095 | |
| Oct 2026 | 30.55 | 31.43 | 26.96 | 28.24 | -8.31% | 13,017,700 | |
| Sep 2026 | 36.79 | 39.33 | 30.19 | 30.80 | -16.55% | 11,820,100 | |
| Aug 2026 | 38.51 | 43.00 | 36.25 | 36.91 | -4.80% | 11,781,400 | |
| Jul 2026 | 43.38 | 47.50 | 36.25 | 38.77 | -8.71% | 12,461,100 | |
| Jun 2026 | 35.15 | 44.50 | 32.45 | 42.47 | +20.62% | 17,619,100 | |
| May 2026 | 40.59 | 41.66 | 28.54 | 35.21 | -13.13% | 21,381,200 | |
| Apr 2026 | 36.16 | 42.13 | 34.13 | 40.53 | +14.95% | 10,061,300 | |
| Mar 2026 | 53.51 | 54.29 | 33.03 | 35.26 | -34.92% | 23,732,800 | |
| Feb 2026 | 43.53 | 54.49 | 42.78 | 54.18 | +32.34% | 10,475,300 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Harrow Inc (HROW) Q3 2026 Earnings Call Highlights: Record Revenue of $99. ... (opens in a new tab) GuruFocus.com · 11 Nov 2026 07:04
- BTIG Reiterates Buy on Harrow, Maintains $63 Price Target (opens in a new tab) Benzinga · 11 Nov 2026 05:46
- Harrow (HROW) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 10 Nov 2026 20:34
- Harrow Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 10 Nov 2026 15:15
- Harrow, Inc. (HROW) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 14:10
- Harrow Health, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 10 Nov 2026 13:30
- Harrow Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 10 Nov 2026 10:30
- Harrow (HROW) Reports Q3 Earnings: What Key Metrics Have to Say (opens in a new tab) Zacks · 09 Nov 2026 23:00
- Harrow (HROW) Q3 Earnings Lag Estimates (opens in a new tab) Zacks · 09 Nov 2026 22:35
- Harrow: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 09 Nov 2026 21:33
- Harrow Announces Third Quarter 2026 Financial Results (opens in a new tab) 09 Nov 2026 21:02
- Harrow Affirms FY2026 Sales Guidance of $350.000M-$365.000M vs $349.747M Est (opens in a new tab) Benzinga · 09 Nov 2026 17:43
- Harrow Q3 EPS $0.25 Beats $0.22 Estimate, Sales $99.297M Beat $98.501M Estimate (opens in a new tab) Benzinga · 09 Nov 2026 17:03
- Harrow (HROW) Launches HarrowRx, Is The Stock Still Undervalued? (opens in a new tab) Simply Wall St. · 07 Nov 2026 14:12
- Learn Why The Bull Case For Harrow (HROW) Could Change Following Pharmacy Platform Launch (opens in a new tab) Simply Wall St. · 05 Nov 2026 02:10
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 28.30 USD
- Market cap
- 1.1B
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow HROW and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.